Navigation Links
Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
Date:6/4/2008

NEW ROCHELLE, N.Y., June 4 /PRNewswire/ -- Ion-channel research is drawing increasing attention from a wide variety of life science investigators all over the globe, reports Genetic Engineering and Biotechnology News (GEN). Such interest is not surprising as ion channels play key roles in numerous biological processes such as neural signal transduction, cardiac, skeletal, and smooth muscle contraction, and epithelial transport of nutrients and ions, among others, according to an article in the June 1 issue of GEN (http://www.genengnews.com/articles/chitem.aspx?aid=2484).

"Research on ion channels has opened up possibilities for new ways to treat a host of diseases, including cancer, a malfunctioning immune system, and cardiovascular and metabolic disorders," notes John Sterling, Editor in Chief of GEN.

On the basic research side, Merritt Maduke, PhD, assistant professor in the department of molecular and cellular physiology at Stanford University School of Medicine, has built a lab focused on elucidating the molecular mechanisms underlying the function of the CLC chloride channels, the largest molecular family of mammalian anion channels. Dr. Maduke's interest in the CLC family is that half of the members are chloride channels, while the other half are chloride-proton antiporters.

In the bioindustry, the real challenge in developing therapeutics based on ion-channel research is the size of ion-channel families and their widespread distribution. The ongoing focus for the development of therapeutics with channel specificity is to develop subtype selectivity to improve efficacy and reduce the impact of side effects.

At Devgen, the focus is on treatment for inflammatory and metabolic diseases and arrhythmia. Petra Blom, PhD, section leader within the medicinal chemistry group, and Titus Kaletta, PhD, head of preclinical development, are working on a project targeting the Kv4.3 ion channel. The goal of their work is to develop a first-in-class oral treatment for acute and chronic atrial fibrillation.

Also discussed in the GEN article is ion-channel work at Organon Laboratories, ChanTest, Molecular Devices and Axon Instruments (both now part of MDS Analytical Technologies), Sophion Bioscience, Nanion Technologies, and Flyion.

For a copy of the June 1 issue of GEN, please call 914.740.2122, or email: ebicovny@liebertpub.com

Genetic Engineering and Biotechnology News (http://www.genengnews.com), which is published 21 times a year by Mary Ann Liebert, Inc., is the most widely read biotechnology news magazine worldwide. It includes articles on Drug Discovery, Bioprocessing, OMICS, Biobusiness, and Clinical Research and Diagnostics.

Contact: John Sterling

Editor in Chief

Genetic Engineering & Biotechnology News

914.740.2196

jsterling@genengnews.com


'/>"/>
SOURCE Genetic Engineering & Biotechnology News
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
2. Presentation of Data on Progens Cancer Epigenetic Targets Platform
3. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate
4. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
5. deCODE Discovers Novel Genetic Links Between Pigmentation Traits and Risk of Skin Cancer
6. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
7. Genetic Immunity Announces Data Related to the DermaVir Nanomedicine Patch in the Journal of Immunology
8. Preclinical Study Shows CTIs Brostallicins Cancer-Killing Ability Based on Genetic Profiling
9. Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy
10. Navigenics(TM) Genome Analysis Used In Research Trial on the Impact of Providing Genetic Risk Assessments
11. Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... N.J. , Dec. 3, 2016  Findings ... and safety of CTL019, an investigational chimeric antigen ... (r/r) pediatric and young adult patients with B-cell ... during an oral session at the 58th American ... December 3, 4:00-5:30 p.m.). The global Phase II ...
(Date:12/2/2016)... bioLytical Laboratories, un líder mundial en test rápidos de ... Self Test , a los miembros de la Kenya Pharmaceutical Association. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ... (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical fue invitada por la Clinton ...
(Date:12/2/2016)... According to the latest market report ... Automated Endoscope Reprocessors: Single Basin Automated Endoscope Reprocessors Product Type ... and 2024 " the global automated endoscope reprocessors market was valued at US$ ... a CAGR of 7.2% during an eight-year forecast period 2016-2024, ... 2024. ...
Breaking Medicine Technology:
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in New York City, with long-time partners The Paul Foundation, on November 10, ...
(Date:12/4/2016)... ... 04, 2016 , ... "Pro3rd Displace is a set of ... displacement design elements," said Christina Austin - CEO of Pixel Film Studios. ... of design styles that include both left aligned and right aligned options for ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global ... Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New York ... who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the ...
(Date:12/2/2016)... ... 02, 2016 , ... Advanced Inc., a leading provider of travel therapy and ... to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously ... financial and operational leadership experience to Advanced Inc. He began his career in finance ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain management programs ... patients must find the one that works for them. When an inventor from Suisun ... that worked and decided to share it with others. , He developed a prototype ...
Breaking Medicine News(10 mins):